United States
US 12,697,387 B2
Chimeric antigen receptors targeting CD19 and use thereof
US 12,697,387 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: MILLENNIUM PHARMACEUTICALS, INC.; MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES; SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH; MEMORIAL SLOAN-KETTERING CANCER CENTER. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- MILLENNIUM PHARMACEUTICALS, INC.; MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES; SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH; MEMORIAL SLOAN-KETTERING CANCER CENTER
- Inventors
- Judith FEUCHT; Jorge MANSILLA-SOTO; Isabelle RIVIERE; Michel SADELAIN; Loic VINCENT; Gary SHAPIRO; Mei Rosa NG; Dan TAVARES; Xingyue HE
- Publication date
- 2026-08-04
- Filing date
- 2022-10-24
- Document type
- B2 Granted patent
- Also written as
- US 12,697,387 B2 · US12697387 · 12697387
Abstract
The presently disclosed subject matter provides chimeric antigen receptors (CARs) that specifically target CD19 and cells comprising such CD19-targeted CARs. The presently disclosed subject matter further provides uses of the CD19-targeted CARs for treatment, e.g., for treating blood cancer.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free